Martin K. Himmelbauer

Martin K. Himmelbauer

Auto-generated profile, based on publicly available information

Martin K. Himmelbauer

Biogen, Pharmaceutical Operations and Technology , 225 Binney Street

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
THTamara Halkina
Tamara Halkina
JHJaclyn L. Henderson
Jaclyn L. Henderson
ELEdward Y. Lin
Edward Y. Lin
MHMartin K. Himmelbauer
Martin K. Himmelbauer
JJJ. Howard Jones
J. Howard Jones
FTFelix Gonzalez-Lopez de Turiso
Felix Gonzalez-Lopez de Turiso

7 May 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
MHMartin K. Himmelbauer
Martin K. Himmelbauer
BBBekim Bajrami
Bekim Bajrami
RBRebecca Basile
Rebecca Basile
ACAndrew Capacci
Andrew Capacci
TCTeYu Chen
TeYu Chen
BHBrian T. Hopkins
Brian T. Hopkins
Multiple sclerosis (MS) is a chronic disease with an underlying pathology characterized by inflammation-driven neuronal loss, axonal injury, and demyelination. Bruton’s tyrosine kinase (BTK), a nonreceptor tyrosine kinase and member of the TEC family of kinases, is involved in the regulation, migration, and functional activation of B cells and myeloid cells in the periphery and the central nervous system (CNS), cell types which are deemed central to the pathology contributing to disease progression in MS patients. Herein, we describe the discovery of BIIB129 (25), a structurally distinct and brain-penetrant targeted covalent inhibitor (TCI) of BTK with an unprecedented binding mode responsible for its high kinome selectivity. BIIB129 (25) demonstrated efficacy in disease-relevant preclinical in vivo models of B cell proliferation in the CNS, exhibits a favorable safety profile suitable for clinical development as an immunomodulating therapy for MS, and has a low projected total human daily dose.

23 May 2016 in European Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
JFJean‐Baptiste Farcet
Jean‐Baptiste Farcet
JMJohann Mulzer
Johann Mulzer
MHMartin K. Himmelbauer
Martin K. Himmelbauer
Relying on our previous achievements toward the a total synthesis of bielschowskysin, 1-5 we herein report additional efforts to close the bridged tetradecane carbocyclic core of this marine diterpene. The key step of this strategy is an intramolecular alkylation between a cis-substituted vinyl halide and a lactone that were accessed by a diastereoselective propargylation/hydrogenation sequence and palladium-catalyzed carbonylation, respectively.

17 March 2025 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
CMCathy A. Muste
Cathy A. Muste
CGChungang Gu
Chungang Gu
HVH. George Vandeveer
H. George Vandeveer
SSSimone Sciabola
Simone Sciabola
MHMartin K. Himmelbauer
Martin K. Himmelbauer

28 October 2026 in Organic Process Research & Development
Verified
Journal Article
Closed access
SMSteven Mathieu
Steven Mathieu
CLChaomin Li
Chaomin Li
NFNicolette Fernandes
Nicolette Fernandes
LSLianyong Shi
Lianyong Shi
YJYe Ji
Ye Ji
BHBrian T. Hopkins
Brian T. Hopkins